FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and endocrinology, and concerns insulin resistance correction in metabolic syndrome. That is ensured by the introduction of Krusmarin containing omega-3 fatty acids and alkyl diglycerides, 5-6 capsules 3 times a day for 15 days with an interval for 15 days for the course of 1 year.
EFFECT: introduction of Krusmarin in the presented regimen ensures the effective insulin resistance correction and the absence of by-effects in the given group of patients due to normalising synergetic action of omega-3 fatty acids and alkyl diglycerides on carbohydrate and lipid metabolism.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RISK EVALUATION OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC CHOLECYSTITIS | 2009 |
|
RU2403868C1 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD FOR PREDICTION OF RISK OF METABOLIC SYNDROME | 2013 |
|
RU2530770C1 |
| METHOD OF TREATING PATIENTS WITH METABOLIC SYNDROME | 2018 |
|
RU2699508C1 |
| METHOD FOR PATIENT-SPECIFIC PREDICTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES WITH CARDIOVASCULAR RISK FACTORS AGED 35-45 YEARS | 2013 |
|
RU2536829C1 |
| METHOD OF DIFFERENTIATED ADMINISTRATION OF MOXONIDINE IN PATIENTS WITH ARTERIAL HYPERTENSION AT BACKGROUND OF METABOLIC SYNDROME | 2010 |
|
RU2426543C1 |
| METHOD FOR DISLIPIDEMIA PREVENTION | 2016 |
|
RU2621152C1 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
| METHOD OF TREATING METABOLIC SYNDROME IN EMOTIOGENIC TYPE OF EATING BEHAVIOUR | 2015 |
|
RU2591811C1 |
